TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio News-Medical.Net 2d
Trimtech Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop Trimtac and Trimglue Targeted Protein Degradation Portfolio Business Wire (Press Release) 2d
TRIMTECH Therapeutics seed round tops £35m BusinessCloud.co.uk 18h TRIMTECH Therapeutics Venture Capital Cambridge (city) All sources
Brevel moves into plant cell culture with Coffeesai partnership Food & Drink International 1d Brevel Food & Drink All sources
